Finasteride can be taken with or without food
Posted by admin on May 4th, 2008 under finasteride proscar | No Comments »
Finasteride can be taken with or without food.
It is important to take finasteride regularly to get the most benefit.
Your doctor may perform blood tests or other forms of monitoring during treatment with finasteride. One of the tests that may be performed is called PSA (prostate-specific antigen). This test is used to help detect prostate cancer. Finasteride will reduce the amount of PSA measured in the blood. Your doctor is aware of this effect and can still use PSA to help detect prostate cancer.
Stop taking finasteride and seek emergency medical attention if you experience an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives).Other, less serious side effects have been reported but usually resolve with continued treatment. Continue to take finasteride and notify your doctor if you experience
- decreased libido (sex drive);
- decreased volume of ejaculate;
- impotence (trouble getting or keeping an erection); or
- breast tenderness or enlargement.
The authors, who surveyed more than 17,000 men 55 and older for seven years, reported their results in the Journal of the National Cancer Institute. The study found that men given finasteride reported on average more dysfunction than did men given a placebo. That small effect diminished over the seven years.
The results allay concerns about a negative side effect associated with finasteride up till now. Physicians usually warn that sexual dysfunction is a possibility when they discuss the drug with patients. Finasteride is an FDA-approved drug for the treatment of benign prostatic hyperplasia, but it is not yet FDA-approved for the prevention or reduction in risk for prostate cancer.
The study’s large sample and long follow-up period allowed researchers to examine whether or not finasteride negatively affected sexual function and, if so, whether this effect was lasting, said Carol Moinpour, Ph.D., of the Fred Hutchison Cancer Research Center in Seattle, the study’s lead author. She coordinates quality-of-life studies for the Southwest Oncology Group, the nation’s largest National Cancer Institute-funded clinical trials network.
